385 related articles for article (PubMed ID: 29447370)
21. Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.
Hughes JC; Wallace JL; Bryant CL; Salvig BE; Fourakre TN; Stone WJ
Ann Pharmacother; 2017 Apr; 51(4):301-306. PubMed ID: 27881692
[TBL] [Abstract][Full Text] [Related]
22. An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of Gout.
Nuki G
Curr Opin Rheumatol; 2014 Mar; 26(2):152-61. PubMed ID: 24492863
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.
Janssen CA; Oude Voshaar MAH; Ten Klooster PM; Vonkeman HE; van de Laar MAFJ
Clin Rheumatol; 2019 Aug; 38(8):2233-2239. PubMed ID: 31030363
[TBL] [Abstract][Full Text] [Related]
24. 2020 American College of Rheumatology Guideline for the Management of Gout.
FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
Arthritis Rheumatol; 2020 Jun; 72(6):879-895. PubMed ID: 32390306
[TBL] [Abstract][Full Text] [Related]
25. Physician adherence to ACR gout treatment guidelines: perception versus practice.
Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive dietary education in treated gout patients does not further improve serum urate.
Holland R; McGill NW
Intern Med J; 2015 Feb; 45(2):189-94. PubMed ID: 25495503
[TBL] [Abstract][Full Text] [Related]
27. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
Hill EM; Sky K; Sit M; Collamer A; Higgs J
J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
[TBL] [Abstract][Full Text] [Related]
28. Adherence to uric acid treatment guidelines in a rheumatology clinic.
Conway R; Coughlan RJ; Carey JJ
Clin Rheumatol; 2012 Dec; 31(12):1707-11. PubMed ID: 22948225
[TBL] [Abstract][Full Text] [Related]
29. Gout in a rheumatology clinic: results of EULAR/ACR guidelines-compliant treatment.
Slot O
Scand J Rheumatol; 2018 May; 47(3):194-197. PubMed ID: 28891365
[TBL] [Abstract][Full Text] [Related]
30. The challenges of managing gout in primary care: Results of a best-practice audit.
Stamp LK; Chapman P; Hudson B; Frampton C; Hamilton G; Judd A
Aust J Gen Pract; 2019 Sep; 48(9):631-637. PubMed ID: 31476837
[TBL] [Abstract][Full Text] [Related]
31. Adherence and persistence to urate-lowering therapies in the Irish setting.
McGowan B; Bennett K; Silke C; Whelan B
Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
[TBL] [Abstract][Full Text] [Related]
32. Gout, urate-lowering therapy, and uric acid levels among adults in the United States.
Juraschek SP; Kovell LC; Miller ER; Gelber AC
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):588-92. PubMed ID: 25201123
[TBL] [Abstract][Full Text] [Related]
33. Patients with severe gout treated in mixed settings.
Rasmussen C; Larsen MB; Linauskas A
Dan Med J; 2021 Oct; 68(11):. PubMed ID: 34983730
[TBL] [Abstract][Full Text] [Related]
34. [Gout management: an update].
Ankli B; Krähenbühl S
Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
[TBL] [Abstract][Full Text] [Related]
35. Management of Gout in a Hospital Setting: A Lost Opportunity.
Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
[TBL] [Abstract][Full Text] [Related]
36. A survey of the assessment and management of gout in general practitioners and medical officers within the Illawarra Network, Australia.
Terrill M; Riordan J
Int J Rheum Dis; 2017 Aug; 20(8):990-995. PubMed ID: 27153502
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population.
Pui K; Gow PJ; Dalbeth N
J Rheumatol; 2013 Jun; 40(6):872-6. PubMed ID: 23457380
[TBL] [Abstract][Full Text] [Related]
38. Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019.
Jansen TL; Janssen M
Clin Rheumatol; 2020 Jun; 39(6):2011-2016. PubMed ID: 32318971
[TBL] [Abstract][Full Text] [Related]
39. Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.
Honda M; Horiuchi H; Torii T; Nakajima A; Iijima T; Murano H; Yamanaka H; Ito S
BMC Pediatr; 2021 Dec; 21(1):581. PubMed ID: 34922491
[TBL] [Abstract][Full Text] [Related]
40. An update on the management of gout.
Drug Ther Bull; 2018 Jan; 56(1):9-12. PubMed ID: 29326278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
